External Ventricular Drainage (EVD) System Market: By Product Type (Ventricular Drainage Catheters, Collection and Drainage Systems, Accessories), By Indication (Hydrocephalus, Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage), By Technology (Conventional Systems, Smart EVD Systems), By End-User (Hospitals, Specialized Neurology Centers, Trauma Centers, Ambulatory Surgical Centers), By Geography (North America, Europe, Asia, Pacific, Latin America, and MEA) and forecast to 2030.

External Ventricular Drainage (EVD) System Market was valued at USD 6,912.3 million in 2023 and is expected to grow at a CAGR of 6.4% from 2024 to 2030. EVD systems are critical neurosurgical devices used to manage intracranial pressure (ICP) and drain cerebrospinal fluid (CSF) in patients with various neurological conditions. The market growth is driven by an increasing prevalence of neurological disorders, technological advancements in EVD systems, and growing awareness about neurocritical care. Hydrocephalus, a condition characterized by excessive CSF accumulation, affects approximately 2 in 1,000 births in United States, necessitating CSF diversion procedures. Traumatic brain injury (TBI), another key indication for EVD use, accounts for about 2.8 million emergency department visits annually in the United States alone.

These statistics underscore the significant demand for EVD systems. Technological innovations, such as the integration of ICP sensors and smart drainage control mechanisms, are enhancing the efficacy and safety of EVD procedures. For instance, smart EVD systems with automated drainage control based on real-time ICP measurements are gaining traction, reducing the risk of over-drainage and improving patient outcomes. However, challenges such as the risk of catheter-related infections and the high cost of advanced EVD systems may hinder market growth. The infection rate associated with EVD procedures ranges from 5% to 20%, emphasizing the need for improved infection control measures.

External Ventricular Drainage (EVD) System Market Key Developments:

In 2023, Medtronic launched the StrataMR  adjustable pressure valve and shunt system, specifically designed to: 

• Enhance MRI compatibility, ensuring that patients can undergo magnetic resonance imaging without the need to adjust or remove the valve. 
• Reduce the risk of over-drainage and related complications through advanced flow-control technology, improving overall patient safety and outcomes.
• Enable precise control of cerebrospinal fluid (CSF) drainage in patients with hydrocephalus, allowing for non-invasive adjustments to the valve settings.